TEL AVIV/ZURICH Israeli start-up Redefine Meat plans to launch 3D printers to produce plant-based steaks mimicking real beef next year in a bid for a slice of the fast-growing alternative meat market. Meat substitutes are increasingly popular with consumers concerned about animal welfare and the environment, boosting sales at Beyond Meat , Impossible Foods and Nestle . Redefine Meat, based in Rehovot, south of Tel Aviv, will first market test its "Alt-Steak" at high-end restaurants this year before rolling out its industrial-scale 3D printers to meat distributors in 2021. "You need a 3D printer to mimic the structure of the muscle of the animal," CEO Eshchar Ben-Shitrit told Reuters. | Video
TEL AVIV Technology developed by Israeli cyber security company NSO Group was used by the Moroccan government to spy on journalist Omar Radi, a critic of Morocco's human rights record, Amnesty International said on Monday.
TEL AVIV An Israeli company expects a fabric it has developed will be able to neutralise close to 99% of the coronavirus, even after being washed multiple times, following a successful lab test.
TEL AVIV The coronavirus crisis may be pushing El Al Israel Airlines back into the hands of the state, less than two decades after the flag carrier was privatised. | Video
TEL AVIV, June 7 The Tel Aviv Stock Exchange
said the market will remain shut on Sunday after it was notified
by the union that workers would take action to protest the
breakdown of talks over an annual bonus payment from 2017.
TEL AVIV Tel Aviv's Bloomfield Stadium has installed a special tunnel to spray soccer players arriving for matches with a fine disinfectant mist to help prevent the spread of the new coronavirus.
TEL AVIV, May 26 Israeli defence electronics
firm Elbit Systems reported higher quarterly
profit on Tuesday and said its business has not been
substantially impacted by the coronavirus outbreak.
TEL AVIV Israel's Sonovia Ltd, which makes washable and reusable anti-viral masks, is considering going public on Nasdaq by the end of this year, its chief technology officer said.
BEIJING/TEL AVIV Teva Pharmaceutical said on Monday that China has given the go-ahead to its Austedo treatment for Huntington's disease.